Section 338.3120. Schedule 3; stimulants; depressants; nalorphine.

(1) Unless specifically excepted or unless listed in another schedule, a material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers whether optical, position, or geometric, and the salts of such isomers, when the existence of such salts, isomers, and the salts of isomers is possible within the specific chemical designation, is included in schedule 3:

(a)    Benzphetamine.

(b)    Chlorphentermine.

(c)    Clortermine.

(d)    Phendimetrazine.

(2)    Unless specifically excepted or unless listed in another schedule, a material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers whether optical, position, or geometric, and the salts of such isomers, when the existence of such salts, isomers, and the salts of isomers is possible within the specific chemical designation, is included in schedule 3:

(a)    Chlorhexadol.

(b)    Embutramide.

(c)      Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal food, drug, and cosmetic act of 1938, 21 U.S.C.§301 et seq.

(d)    Ketamine.

(e)    Lysergic acid.

(f)    Lysergic acid amide.

(g)    Methyprylon.

(h)    Perampanel.

(i)    Pentazocine.

(j)    Sulfondiethylmethane.

(k)    Sulfonethylmethane.

(l)    Sulfonmethane.

(m)    Tiletamine-zolazepam.

(3)      A compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or a salt thereof and 1 or more other active medicinal ingredients that are not listed in a schedule is included in schedule 3.

(4)        A suppository dosage form which contains amobarbital, secobarbital, pentobarbital, or a salt of any of these drugs and which is approved by the food and drug administration for marketing only as a suppository is included in schedule 3.

(5)   A substance that contains any quantity of a derivative of barbituric acid or any salt thereof is included in schedule 3.

(6)   Nalorphine is included in schedule 3.

(7)   Buprenorphine is included in schedule 3.

History:  1979 AC; 1982 AACS; 1988 AACS; 1992 AACS; 2002 AACS; 2007 AACS; 2016 MR 8, Eff.